Protective and enhancing interactions among dengue viruses 1-4 and Zika virus
- 24 September 2020
- journal article
- research article
- Published by Elsevier in Current Opinion in Virology
- Vol. 43, 59-70
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 124 references indexed in Scilit:
- Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study YearPLOS Neglected Tropical Diseases, 2013
- Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic EpitopePLOS Pathogens, 2012
- Identification of human neutralizing antibodies that bind to complex epitopes on dengue virionsProceedings of the National Academy of Sciences, 2012
- A Fusion-Loop Antibody Enhances the Infectious Properties of Immature Flavivirus ParticlesJournal of Virology, 2011
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in HumansScience, 2010
- Dengue 1 Virus and Dengue Hemorrhagic Fever, French Polynesia, 2001Emerging Infectious Diseases, 2009
- Differential Modulation of prM Cleavage, Extracellular Particle Distribution, and Virus Infectivity by Conserved Residues at Nonfurin Consensus Positions of the Dengue Virus pr-M JunctionJournal of Virology, 2008
- Essential Role of Dengue Virus Envelope Protein N Glycosylation at Asparagine-67 during Viral PropagationJournal of Virology, 2007
- Relationship of Preexisting Dengue Virus (DV) Neutralizing Antibody Levels to Viremia and Severity of Disease in a Prospective Cohort Study of DV Infection in ThailandThe Journal of Infectious Diseases, 2004
- Shock associated with dengue infectionThe Journal of Pediatrics, 1966